Sevion Therapeutics, Inc.
Records under this name other than patents Sevion Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Sevion Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,232,455 | Polynucleotides encoding canola DHS and antisense polynucleotides thereof Formerly held Term ended Term ended Jan 25, 2022 · USPTO record | Term ended | Term ended Jan 25, 2022 | USPTO record |
| US 7,663,028 | Method of Increasing Seed Yield and Growth EIF-5A Formerly held Term ended Term ended Apr 27, 2020 · Medium confidence | Term ended | Term ended Apr 27, 2020 | Medium confidence |
| US 7,358,418 | Isoforms of EIF-5A: Senescence-Induced ELF5A; Wounding-Induced EIF-5A; Growth EIF-5A; and DHS Formerly held Term ended Term ended Jan 17, 2020 · Medium confidence | Term ended | Term ended Jan 17, 2020 | Medium confidence |
| US 7,087,419 | DNA Encoding a Plant Lipase, Transgenic Plants and a Method for Controlling Senescence in Plants Formerly held Lapsed on the fee record Ended Aug 8, 2018 · Medium confidence | Lapsed on the fee record | Ended Aug 8, 2018 | Medium confidence |